Blog

Accesso Technology Group (LSE:ACSO) reported modest revenue growth in 2025, with sales rising to $155.1 million while profitability improved significantly. Statutory profit before tax increased by nearly 38%, and adjusted earnings per share climbed more than 15%. Although transactional revenue softened due to weaker discretionary consumer spending, the company benefited from strong demand for professional services, tight cost management and an improved net cash position.

Operationally, Accesso secured 43 new venue contracts during the year and saw strong adoption of its accesso Freedom platform, expanding its software-as-a-service footprint and reinforcing its base of recurring revenue. The company also accelerated the integration of artificial intelligence across its operations and product development roadmap. Efficiency measures included a reduction in headcount, while shareholder returns were strengthened through share buybacks and a tender offer completed after the year-end.

The group also pointed to changes within its virtual queuing portfolio. While one major LoQueue customer was lost, the impact was partly offset by extended and expanded agreements with another key client, highlighting the resilience of its diversified platform. On the leadership front, long-serving CEO Steve Brown announced plans to step down following a structured succession process. Chief Operating Officer Lee Cowie is expected to assume the role of CEO in May 2026, ensuring strategic continuity as the company enters its next phase of growth.

The company’s outlook is supported by improving margins, a low-leverage balance sheet and generally strong cash conversion, alongside a reasonable price-to-earnings valuation. However, technical indicators remain weak, with the share price trading well below major moving averages and showing negative momentum. Management commentary was mixed but broadly constructive, pointing to a stronger pipeline and ongoing strategic initiatives despite near-term softness in some segments and continued cost pressures.

More about accesso Technology

Accesso Technology Group is a UK-listed provider of technology solutions for attractions and entertainment venues worldwide, including theme parks, cultural attractions and leisure operators. Its product suite includes ticketing systems, virtual queuing technology, e-commerce platforms and SaaS offerings such as accesso Freedom. The company is increasingly focused on incorporating AI-driven analytics and tools to enhance guest commerce and improve operational efficiency for venue operators.

Clean Power Hydrogen (LSE:CPH2) has shipped its first 1MW MFE220 membrane-free electrolyser to a dedicated testing facility for the final phase of factory acceptance testing. The project remains on schedule for site acceptance during the third quarter of 2026, when the company expects to begin generating its first commercial revenues. CPH2 currently has firm orders for four units and is growing its sales pipeline across the UK, Europe, India and the Middle East. It has also entered into several non-binding collaboration agreements linked to zero-carbon initiatives, Middle Eastern energy projects and Indian agritech applications, with potential project sizes of up to 20MW each.

The company has also signed a non-binding agreement with Siemens to explore opportunities to scale manufacturing and accelerate technology development. The collaboration is expected to support product design improvements, process optimisation and broader market deployment. Meanwhile, CPH2’s MFE110 demonstrator unit has achieved independently verified hydrogen purity of 99.999vol% and oxygen purity of 99.7%. These performance levels could allow the company to generate additional revenue through oxygen sales while lowering the lifetime cost of hydrogen production. The company is also developing next-generation 1MW and 5MW systems designed to improve efficiency and potentially enable negative-cost hydrogen production in certain use cases.

The company’s outlook remains weighed down by weak financial fundamentals, including minimal revenue, expanding losses and significant cash burn that has reduced its equity base. Technical indicators offer some support, with the share price showing an upward trend and positive momentum, although a relatively high RSI suggests the possibility of a near-term pullback. Valuation metrics remain difficult to assess given the company’s loss-making status and the absence of dividend yield data.

More about Clean Power Hydrogen PLC

Clean Power Hydrogen plc (CPH2) develops membrane-free electrolyser technology designed to produce high-purity hydrogen alongside above medical-grade oxygen. The company targets decentralised hydrogen production markets, aiming to reduce the levelised cost of hydrogen for applications such as wastewater treatment, curtailed renewable power utilisation, data centres, medical and life sciences, and heavy-duty mobility. Its shares are listed on London’s AIM market under the ticker CPH2.

Frontier IP Group (LSE:FIPP) reported an unaudited pre-tax loss of £3.1 million for the six months to 31 December 2025. The result was largely influenced by non-cash IFRS 16 lease accounting charges related to its SC2 innovation hub and a downward fair-value adjustment in one of its portfolio companies. Operating costs were reduced to £1.6 million following a series of cost rationalisation measures, and the group has outlined plans to implement additional savings of around £1 million annually from May 2026 as it tightens financial discipline amid challenging conditions in AIM-listed and early-stage technology markets.

During the period, the company raised £0.9 million through equity issuances—below its original target—and is now seeking further funding through a combination of equity and debt. Net assets per share declined to 52.7p, while cash balances fell to £1.6 million. Despite these financial pressures, several portfolio companies achieved important technical, commercial and funding milestones. These included significant fundraising rounds and international agreements for Pulsiv, Alusid and Amprologix, promising vaccine trial progress at The Vaccine Group, and continued strategic development at companies such as 2D Photonics and GraphEnergyTech. These developments support Frontier IP’s longer-term strategy of building value through the commercialisation of early-stage technologies.

The company’s outlook remains constrained by recurring losses, continued cash outflows and increased leverage introduced in 2025. Technical indicators also remain weak, with the share price trading well below key moving averages and showing negative MACD momentum. Valuation metrics provide limited support due to a negative price-to-earnings ratio and the absence of dividend yield data.

More about Frontier IP

Frontier IP Group is a UK-based company focused on commercialising intellectual property by creating and scaling spin-out businesses from universities and industry research. The group collaborates with academic institutions, investors and corporate partners to develop early-stage technology ventures across areas including advanced materials, clean technology, digital solutions and life sciences. Its strategy centres on building value in these companies as they mature toward potential commercial success and exit opportunities.

Jangada Mines (LSE:JAN) has announced encouraging geological results from its ongoing diamond drilling campaign at the Molly Gold Project in Brazil’s Tapajós Gold Province. All 13 drill holes completed so far have intersected quartz veining and/or disseminated sulphides linked to gold mineralisation. The exploration programme has been expanded to approximately 2,480 metres and is fully funded, with the goal of upgrading and significantly expanding the project’s existing 130,000-ounce JORC inferred resource. Initial assay results from 44 samples are expected in mid-April, followed by an updated resource estimate.

Step-out drilling at the Molly 2 target, along with additional drilling east and west of the Molly 1 zone, has highlighted the broader district-scale potential of the project. In response to these results, the company has decided to exercise its option to acquire 100% of the 6,656.2-hectare Molly project from BGold. The transaction will begin with an initial consideration of US$350,000 in a mix of cash and shares, subject to regulatory approvals. Phase 1 drilling is expected to conclude in early April, after which Phase 2 exploration—including mapping, geophysical surveys, geochemical sampling and trenching—will continue through to late 2026. Management believes the project could ultimately develop into a multi-pit, high-grade gold system, potentially strengthening Jangada’s resource base and positioning within one of Brazil’s key gold regions.

The company’s outlook remains constrained by its early-stage financial profile, characterised by a lack of revenue, recurring losses and ongoing cash burn, although it currently carries no debt. On the technical side, the share price is trading above key moving averages with moderately positive momentum indicators. However, valuation metrics remain limited by the company’s loss-making position and the absence of dividend support.

More about Jangada Mines PLC

Jangada Mines plc is an AIM-listed natural resources development company focused on projects in Brazil. Its portfolio includes the high-grade Molly Gold Project, the Paranaíta Gold Project and the fully owned Pitombeiras vanadium titanomagnetite project. Drawing on industry expertise, financial resources and local operational knowledge, the company aims to advance its existing assets while identifying and progressing additional resource opportunities across Brazil to build long-term shareholder value.

Mirriad Advertising (LSE:MIRI) said trading in the first quarter of 2026 came in below earlier expectations after geopolitical tensions in the Middle East, including the conflict involving Iran, disrupted anticipated sales growth. The company had expected stronger demand linked to partner activity and seasonal advertising during Ramadan, particularly across Middle Eastern markets. Despite the softer start to the year, Mirriad announced a services agreement with one of the UK’s largest media groups to deploy its virtual product placement technology in a test campaign designed to generate additional revenue opportunities for the client.

As of 27 March 2026, the company reported cash and cash equivalents of roughly £675,000 and said it continues to tightly control operating costs. However, Mirriad expects that additional funding will be required before it publishes its 2025 annual report and accounts. The anticipated capital requirement highlights continued balance sheet pressure even as the company works to strengthen its market presence through new partnerships and commercial initiatives, developments that investors will be monitoring closely.

The company’s outlook remains dominated by weak financial fundamentals, including a sharp decline in revenue, substantial ongoing losses and persistent cash burn that has eroded the balance sheet. With few meaningful technical indicators and limited valuation support—given the negative price-to-earnings ratio and lack of dividend yield—there are currently few counterbalances to these financial risks.

More about Mirriad Advertising

Mirriad Advertising specialises in virtual product placement and in-content advertising technology. Its multi-patented platform allows brands and products to be digitally inserted into television programmes, streaming video-on-demand content, music videos and influencer media. The company aims to create new monetisation opportunities for content owners while improving advertising effectiveness and viewer experience. Mirriad currently operates across EMEA, the United States through a joint venture, and India.

PipeHawk (LSE:PIP) reported significantly weaker trading in its interim results for the six months to 31 December 2025, with revenue declining 45% year-on-year to £1.14m. The group moved from a modest profit in the prior period to a pre-tax loss of £573,000, reflecting slower order intake and rising operating costs. Amid ongoing cash pressures and accumulated liabilities, the company continues to rely on financial backing from its chairman as well as fee deferrals from directors.

Within the group, subsidiary Thomson Engineering Design (TED) has maintained stable operations and is anticipating potential global orders through its partner Unipart. It is also seeking Network Rail approvals for its newly developed RT23 Rail Threader and SL21 Sleeper Laying Machine. Meanwhile, Utsi Electronics is awaiting UK national security clearance for its agreed sale, which is expected to generate capital to support TED’s development and expand Utsi’s technology capabilities. In contrast, survey business Adien has been placed into wind-up after weather disruption and a significant bad debt left it insolvent despite a healthy order pipeline. The closure is expected to remove around £250,000 in net liabilities from the group’s balance sheet, though it highlights the operational and financial challenges facing PipeHawk.

The company’s outlook remains constrained by weak financial fundamentals, including a steep drop in revenue, negative profitability, high leverage and worsening free cash flow. Technical indicators offer only limited support, while valuation remains difficult due to continued losses and the absence of dividend yield data.

More about PipeHawk

PipeHawk plc is a technology and engineering group specialising in rail infrastructure equipment, ground-penetrating radar and related survey services. The company operates through subsidiaries including Thomson Engineering Design (TED), Utsi Electronics and the now-insolvent Adien. PipeHawk focuses on supplying rail and infrastructure markets in the UK and internationally, with its strategy increasingly centred on global expansion through partnerships such as its distribution alliance with Unipart for TED’s rail engineering equipment.

Gaming Realms (LSE:GMR) delivered record financial results for 2025, reporting revenue of £31.4m, up 10% year-on-year, while adjusted EBITDA rose 15% to £15.0m. Growth was driven primarily by a 13% increase in licensing income and improved margins, which expanded to 48%. Strong cash generation boosted the company’s year-end cash position to £17.8m, enabling further investment in game development, the launch of a £6.0m share buyback programme and continued expansion of its Slingo content portfolio and third-party distribution platform.

During the year, the group strengthened its global presence by releasing 12 new proprietary Slingo titles and signing 40 additional operator partners. Gaming Realms also entered several new regulated markets, including Delaware in the United States and multiple jurisdictions across South America, Europe and Africa. Momentum has continued into early 2026 with launches in Peru, Nigeria, Ghana and Kenya, new content produced by Lucky Lunar Studio and ongoing expansion of its core licensing business, reinforcing the company’s role as a major international provider of iGaming content.

The company’s outlook is supported by strong financial fundamentals, including a healthy balance sheet and effective cash flow generation. The share buyback programme also adds to shareholder value. However, technical indicators point to some bearish momentum in the share price, and the absence of a dividend yield may make the stock less appealing to income-focused investors.

More about Gaming Realms

Gaming Realms is a UK-listed developer and licensor of mobile-first iGaming content, widely recognised for its Slingo-branded games that combine elements of slots and bingo. The company operates across key hubs including the UK, the U.S., Canada and Malta, distributing both proprietary and third-party titles through its remote gaming server platform to regulated markets worldwide, with North America representing its largest licensing market.

Abingdon Health (LSE:ABDX) has been awarded contracts worth about £4.8m by a U.S.-based customer to develop and scale multiple multiplex quantitative lateral flow assay systems capable of detecting several biomarkers within human samples. The project will run for 27 months and will begin immediately. It covers full programme oversight, regulatory process management, and both analytical and clinical performance services, delivered through milestone-based work packages that could expand further as the programme progresses.

The contracts will be executed across Abingdon’s sites in York and Madison, drawing on the expertise of its regulatory businesses CS Lifesciences and IVDeology, alongside analytical and performance testing support from Abingdon Analytical in Doncaster. The agreement strengthens the company’s role as an integrated CDMO and CRO partner for the development and manufacture of lateral flow diagnostics, enhancing its commercial pipeline while highlighting demand for its end-to-end service offering among international med-tech clients.

The company’s outlook reflects mixed financial signals. While revenue growth has been strong, profitability and cash flow remain under pressure. Technical indicators point to a largely neutral share price trend without strong momentum. Valuation metrics are also relatively weak due to a negative price-to-earnings ratio and the absence of a dividend yield, resulting in a broadly moderate overall assessment.

More about Abingdon Health PLC

Abingdon Health plc is a UK-based med-tech contract service provider focused on rapid diagnostic technologies. The company operates as a contract development and manufacturing organisation (CDMO), delivering services that include lateral flow assay development, regulatory support, technology transfer and manufacturing. Its solutions support a range of markets, including infectious diseases, clinical and companion diagnostics, animal health and environmental testing across global markets.

Jarvis Securities (LSE:JIM) released interim results for the six months to 31 December 2025 highlighting its ongoing transition toward a full wind-down. Underlying revenue, excluding exceptional items, dropped 74.6% year-on-year to £1.6m, while losses before tax on the same basis widened significantly. However, reported earnings were lifted by a £9m gain from the disposal of the company’s retail execution business, resulting in headline profitability and an improved earnings per share.

The group’s income from interest continues to decline as client balances gradually reduce. In addition, dividend distributions from its subsidiary remain restricted by the Financial Conduct Authority. Management is focused on executing an orderly wind-down, which includes assessing the potential sale of the company’s remaining property assets. The board is also considering cancelling the company’s AIM listing and returning surplus capital to shareholders once the wind-down process has been finalised.

Looking ahead, the company’s position is supported by strong underlying financial stability, characterised by solid profitability and low leverage, along with very low valuation metrics. However, the outlook is tempered by weak technical momentum in the share price and uncertainty around cash generation, with free cash flow reported at zero for 2024.

More about Jarvis Securities

Jarvis Securities plc operates in the financial services sector through its wholly owned subsidiary, Jarvis Investment Management Limited. The business historically provided retail trade execution and investment administration services. Following regulatory challenges and a strategic review, the company sold its core retail execution division and is now focused on an orderly wind-down of its remaining activities while seeking to realise residual value for shareholders.